|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.577
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.383
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.360
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.323
|
|
|
recognition of apoptotic cell
|
GO:0043654 |
3 |
0.317
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.284
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.273
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.266
|
|
|
ossification
|
GO:0001503 |
216 |
0.258
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.241
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.233
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.220
|
|
|
bone development
|
GO:0060348 |
120 |
0.210
|
|
|
lung development
|
GO:0030324 |
164 |
0.191
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.190
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.186
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.184
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.176
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.173
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.164
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.149
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.146
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.145
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.142
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.140
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.135
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.133
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.128
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.123
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.120
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.113
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.113
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.110
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.106
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.105
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.103
|
Human |
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.102
|
|
|
renal system development
|
GO:0072001 |
225 |
0.102
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.099
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.099
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.092
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.092
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.092
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.092
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.086
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.085
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.084
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.084
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.083
|
|
|
protein processing
|
GO:0016485 |
163 |
0.082
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.081
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.080
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.079
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.079
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.074
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.072
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.071
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.071
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.065
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.065
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.064
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.063
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.062
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.060
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.060
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.060
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.060
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.058
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.057
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.056
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.056
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.056
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.056
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.055
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.055
|
|
|
palate development
|
GO:0060021 |
76 |
0.054
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.052
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.051
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.051
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.051
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.051
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.051
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.050
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.050
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.049
|
|
|
limb development
|
GO:0060173 |
166 |
0.049
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.048
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.047
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.047
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.046
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.046
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.046
|
|
|
regulation of cell growth involved in cardiac muscle cell development
|
GO:0061050 |
3 |
0.045
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.045
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.044
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.044
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.044
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.043
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.043
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.042
|
|
|
skin development
|
GO:0043588 |
220 |
0.042
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.041
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.041
|
|
|
aorta smooth muscle tissue morphogenesis
|
GO:0060414 |
2 |
0.040
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.040
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.040
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.039
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.039
|
|
|
protein heterotrimerization
|
GO:0070208 |
8 |
0.039
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.038
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.038
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.038
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.037
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.037
|
|
|
physiological muscle hypertrophy
|
GO:0003298 |
3 |
0.037
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.037
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.036
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.036
|
|
|
ear development
|
GO:0043583 |
200 |
0.036
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.036
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.036
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.036
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.036
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.035
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.034
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.034
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.034
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.034
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.034
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.034
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.034
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.034
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.033
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.033
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.033
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.033
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.033
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.032
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.032
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.032
|
|
|
organ growth
|
GO:0035265 |
117 |
0.032
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.032
|
|
|
regionalization
|
GO:0003002 |
337 |
0.031
|
|
|
pallium development
|
GO:0021543 |
120 |
0.031
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.031
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.031
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.030
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.030
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.030
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.030
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.029
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.029
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.029
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.029
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.029
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.029
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.028
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.028
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.028
|
|
|
cellular response to nitric oxide
|
GO:0071732 |
4 |
0.028
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.027
|
|
|
regulation of neuron migration
|
GO:2001222 |
22 |
0.027
|
|
|
positive regulation of bone resorption
|
GO:0045780 |
13 |
0.027
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.027
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.026
|
|
|
phagolysosome assembly
|
GO:0001845 |
3 |
0.026
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.026
|
|
|
protein trimerization
|
GO:0070206 |
13 |
0.026
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.026
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.026
|
|
|
positive regulation of bone remodeling
|
GO:0046852 |
13 |
0.026
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.026
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.026
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.025
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.025
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.025
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.025
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.025
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.025
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.024
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.024
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.024
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.024
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.024
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.024
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.024
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.023
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.023
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.023
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.023
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.023
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.023
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.023
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.023
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.023
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.022
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.022
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.022
|
|
|
kidney development
|
GO:0001822 |
213 |
0.022
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.022
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.022
|
|
|
aorta development
|
GO:0035904 |
23 |
0.022
|
|
|
antimicrobial peptide secretion
|
GO:0002776 |
1 |
0.022
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.021
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.021
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.021
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.021
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.021
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.021
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.021
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.021
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.021
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.021
|
|
|
response to nitric oxide
|
GO:0071731 |
4 |
0.021
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.021
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.021
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.020
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.020
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.020
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.020
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.020
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.020
|
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.020
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.020
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.019
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.019
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.019
|
|
|
gland development
|
GO:0048732 |
330 |
0.019
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.019
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.019
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.019
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.019
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.019
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.019
|
|
|
midgut development
|
GO:0007494 |
4 |
0.019
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.019
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.019
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.019
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.019
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.019
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.019
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.018
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.018
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.018
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.018
|
|
|
face development
|
GO:0060324 |
38 |
0.018
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.018
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.018
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.018
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.018
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.018
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.018
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.018
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.018
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.018
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.017
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.017
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.017
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.017
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.017
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.017
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.017
|
|
|
positive regulation of tissue remodeling
|
GO:0034105 |
19 |
0.017
|
|
|
notochord development
|
GO:0030903 |
20 |
0.017
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.017
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.017
|
|
|
artery development
|
GO:0060840 |
53 |
0.017
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.017
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.017
|
|
|
insulin processing
|
GO:0030070 |
2 |
0.017
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.017
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.016
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.016
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.016
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.016
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.016
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.016
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.016
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.016
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.016
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.016
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.016
|
|
|
protein heterooligomerization
|
GO:0051291 |
14 |
0.016
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.016
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.016
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.016
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.016
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.016
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.016
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.016
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.016
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.016
|
|
|
cellular response to bmp stimulus
|
GO:0071773 |
14 |
0.016
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.015
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.015
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.015
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.015
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.015
|
|
|
histone modification
|
GO:0016570 |
159 |
0.015
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.015
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.015
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.015
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.015
|
|
|
negative regulation of signal transduction in absence of ligand
|
GO:1901099 |
16 |
0.015
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.015
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.014
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.014
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.014
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.014
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.014
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.014
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.014
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.014
|
|
|
nerve development
|
GO:0021675 |
67 |
0.014
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.014
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.014
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.014
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.014
|
|
|
spinal cord ventral commissure morphogenesis
|
GO:0021965 |
2 |
0.014
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.014
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.014
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.014
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.014
|
|
|
direct ossification
|
GO:0036072 |
5 |
0.014
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.014
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.014
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.014
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.014
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.014
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.014
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.013
|
|
|
negative regulation of macrophage chemotaxis
|
GO:0010760 |
1 |
0.013
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.013
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.013
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.013
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.013
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.013
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.013
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.013
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.013
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.013
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.013
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.013
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.013
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.013
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.013
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.013
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.013
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.013
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.013
|
|
|
somatic sex determination
|
GO:0018993 |
2 |
0.013
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.013
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.013
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.013
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.013
|
|
|
female sex determination
|
GO:0030237 |
1 |
0.013
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.013
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.013
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.013
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.012
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.012
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.012
|
|
|
response to pain
|
GO:0048265 |
26 |
0.012
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.012
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.012
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.012
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.012
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.012
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.012
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.012
|
|
|
endodermal cell differentiation
|
GO:0035987 |
14 |
0.012
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.012
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.012
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.012
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.012
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.012
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.012
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.012
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.012
|
|
|
extracellular matrix assembly
|
GO:0085029 |
12 |
0.012
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.012
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.012
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.012
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.012
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.012
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.012
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.012
|
|
|
lateral ganglionic eminence cell proliferation
|
GO:0022018 |
1 |
0.012
|
|
|
fertilization
|
GO:0009566 |
127 |
0.012
|
|
|
positive regulation of interleukin 6 secretion
|
GO:2000778 |
1 |
0.012
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.012
|
|
|
anion transport
|
GO:0006820 |
177 |
0.012
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.012
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.011
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.011
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.011
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.011
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.011
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.011
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.011
|
|
|
positive regulation of rho protein signal transduction
|
GO:0035025 |
7 |
0.011
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.011
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.011
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.011
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.011
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.011
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.011
|
|
|
negative regulation of chemotaxis
|
GO:0050922 |
11 |
0.011
|
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
9 |
0.011
|
|
|
growth involved in heart morphogenesis
|
GO:0003241 |
4 |
0.011
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.011
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.011
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.011
|
|
|
rna interference
|
GO:0016246 |
2 |
0.011
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.011
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.011
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.011
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.011
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.011
|
|
|
metanephric glomerular basement membrane development
|
GO:0072274 |
1 |
0.011
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.011
|
|
|
positive regulation of neuron projection regeneration
|
GO:0070572 |
2 |
0.011
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.011
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.011
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.011
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.011
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.011
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.011
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.011
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.011
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.011
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.011
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.011
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.011
|
|
|
positive regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030511 |
12 |
0.011
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.011
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.011
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.011
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.011
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.010
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.010
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.010
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.010
|
|
|
nephron development
|
GO:0072006 |
109 |
0.010
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.010
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.010
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.010
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.010
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.010
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.010
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.010
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.010
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.010
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.010
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.010
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.010
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.010
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.010
|
|